Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 9/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.65 |
| ▸ | ALPI | P09923 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | XIAP | P98170 | 1/20 | 0.65 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.60 |
| ▸ | NOS3 | P29474 | 3/20 | 0.59 |
| ▸ | NOS1 | P29475 | 3/20 | 0.59 |
| ▸ | NOS2 | P35228 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14935980 | 1.00 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL44026 | 1.00 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL29567654 | 1.00 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL29400795 | 1.00 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL20502133 | 0.98 | SLC7A5 (0.62) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL22264913 | 0.98 | SLC7A5 (0.62) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL29398308 | 0.98 | SLC7A5 (0.62) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL20502134 | 0.98 | SLC7A5 (0.62) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL31320951 | 0.98 | SLC7A5 (0.62) | SLC7A5PTGS1ALPIPKMXIAP | |
| Leucine SCHEMBL7415976 | 0.90 | NOS3 (0.53) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590137-B2 | Meditope-enabled T cells | CITY OF HOPE (US) | 2026-03-31 | — | — | US | claimed |
| US-20250066418-A1 | CYSTEINE PEPTIDE-ENABLED ANTIBODIES | CITY OF HOPE | 2025-02-27 | — | — | US | claimed |
| CN-119177222-A | Pyrrolysinyl-tRNA synthetase mutant and application thereof | 浙江大学 | 2024-12-24 | — | — | CN | claimed |
| CN-114457049-B | Pyrrolysiyl-tRNA synthetase mutant and application thereof | 浙江大学杭州国际科创中心 | 2024-09-24 | — | — | CN | claimed |
| CN-113481228-B | Microbial unnatural amino acid introducing system and construction method | 中国药科大学 | 2024-07-19 | — | — | CN | claimed |
| US-11897952-B2 | Mechanically interlocking complexes | CITY OF HOPE | 2024-02-13 | — | — | US | claimed |
| CN-117442748-A | Multivalent mimotopes, mimotope binding antibodies and uses thereof | 希望之城公司 | 2024-01-26 | — | — | CN | claimed |
| US-20230391887-A1 | MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF | HOPE CITY (US) | 2023-12-07 | — | — | US | claimed |
| US-20230303647-A1 | CYCLIC CHEMERIN-9 DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-09-28 | — | — | US | claimed |
| CN-116730969-A | Beta-lapachone-amino acid conjugate, and preparation method and application thereof | 中国药科大学 | 2023-09-12 | — | — | CN | claimed |
| WO-2008031016-A2 | HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-13 | — | — | WO | claimed |
| EP-1774018-A2 | SITE SPECIFIC INCORPORATION OF HEAVY ATOM-CONTAINING UNNATURAL AMINO ACIDS INTO PROTEINS FOR CRYSTAL STRUCTURE DETERMINATION | The Scripps Research Institute (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2005122379-A9 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | UNIV CALIFORNIA (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-20050272121-A1 | Translation system including an orthogonal aminoacyl-transfer RNA synthetase with a specific sequence that preferentially aminoacylates an orthogonal transfer RNA with a brominated or iodinated phenylalanine or tyrosine | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-12-08 | — | — | US | claimed |
| WO-2005116237-A2 | SITE SPECIFIC INCORPORATION OF HEAVY ATOM-CONTAINING UNNATURAL AMINO ACIDS INTO PROTEINS FOR CRYSTAL STRUCTURE DETERMINATION | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-12-08 | — | — | WO | claimed |
| US-6867284-B1 | Peptide inhibitors of hepatitis C virus NS3 protease | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2005-03-15 | — | — | US | claimed |
| EP-1084137-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-03-21 | — | — | EP | claimed |
| WO-1999064442-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) | 1999-12-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391887-A1 | MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF | FCGR3B, FCGR2A, CD47 | SLC7A5 3511/4885PTGS1 4790/4885ALPI 1470/4885 |
| US-11897952-B2 | Mechanically interlocking complexes | FCGR3B, FCGR2A, FCGRT | SLC7A5 2742/4885PTGS1 4601/4885ALPI 4028/4885 |
| US-20250066418-A1 | CYSTEINE PEPTIDE-ENABLED ANTIBODIES | LNPEP, CSTB, PTMS | SLC7A5 305/4885PTGS1 3581/4885ALPI 4850/4885 |
| US-20050272121-A1 | Translation system including an orthogonal aminoacyl-transfer RNA synthetase with a specific sequence that preferentially aminoacylates an orthogonal transfer RNA with a brominated or iodinated phenylalanine or tyrosine | AARS1, NSUN3, TARBP1 | SLC7A5 63/4885PTGS1 4329/4885ALPI 4410/4885 |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | SLC7A5 576/4885PTGS1 3492/4885ALPI 3006/4885 |
| US-20230303647-A1 | CYCLIC CHEMERIN-9 DERIVATIVES | CMKLR1, CMKLR2, CCL2 | SLC7A5 3537/4885PTGS1 605/4885ALPI 2013/4885 |
| US-12590137-B2 | Meditope-enabled T cells | CD4, ICOS, CD40 | SLC7A5 708/4885PTGS1 4274/4885ALPI 307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.